(S)-oxybutynin (Sepracor) |
| |
Authors: | Dmochowski Roger R |
| |
Affiliation: | Department of Urology, Vanderbilt University, Nashville, TN 37232, USA. roger.dmochowski@mcmail.vanderbilt.edu |
| |
Abstract: | Sepracor is developing (S)-oxybutynin, a single-isomer version of Alza's Ditropan (racemic oxybutynin), a muscarinic acetylcholine receptor antagonist, as a potential treatment for urinary incontinence. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|